TABLE 3:
Select characteristics of subjects from AIDS Clinical Trials Group studies 175 and 3201
| ACTG 175 | ACTG 320 | |||
|---|---|---|---|---|
| Monotherapy N = 271 | Dual-therapy N = 550 | Dual-therapy N = 579 | Triple-therapy N = 577 | |
| Male Sex | 221 (81.5) | 448 (81.5) | 485 (83.8) | 471 (81.6) |
| Age (Median, IQR) | 35 (30, 41) | 35 (30, 41) | 38 (33, 44) | 38 (33, 44) |
| Black race | 70 (25.8) | 138 (25.1) | 165 (28.5) | 163 (28.2) |
| Injection drug use | 33 (12.2) | 79 (14.4) | 93 (16.1) | 91 (15.8) |
| Karnofsky Score (Mean, SD) | 95.0 (6.3) | 95.4 (6.0) | 91.4 (7.7) | 91.2 (7.7) |
1
All numbers are N (%) unless otherwise noted